Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026 
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle 
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch 
Samsung Signals Comeback With HBM4 Chips as AI Market Heats Up 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro 
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power 
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation 
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital 
Starlink Plans Satellite Orbit Reconfiguration in 2026 to Boost Space Safety 
Boeing Secures Multi-Billion Dollar Defense Contracts for F-15IA Jets and E-4B Aircraft Support 
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel 
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China 
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round 
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics 
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades 
SAN FRANCISCO, Oct. 17, 2017 -- Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, today announced the strengthening of its executive management team with the appointment of Marcia Fish as Chief Human Resources Officer, effective October 2, 2017. She will report to Invuity CEO Phillip Sawyer and will have direct responsibility for the company’s people strategy including talent acquisition, talent development and building organizational capability to further support Invuity’s growth.
Mr. Sawyer said, “We are thrilled to have Marcia join our team and leverage her expertise from her work with both smaller and larger companies as we look to grow our talent base and refine our processes to continue to scale. This is a transformational time for Invuity, and we look forward to Marcia’s contribution.”
Ms. Fish was most recently the Chief Human Resources Officer for Marlin Equity Partners, a private equity firm, where she worked with their portfolio of companies, spanning sectors including healthcare and technology. Prior to that, Ms. Fish spent 21 years at General Electric (GE) in roles of increasing responsibility, including serving as Human Resources lead for several US and ex-US businesses. Ms. Fish has a Bachelor’s degree from Cornell University’s Department of Industrial and Labor Relations and an MBA from Duke University’s Fuqua School of Business.
About Invuity®
Invuity, Inc. is a leading medical technology company focused on developing and marketing advanced surgical devices to improve the ability of physicians to perform minimal access surgery through smaller and hidden incisions. The company's patented Intelligent Photonics™ technology delivers enhanced visualization which facilitates surgical precision, efficiency and safety. In addition, the company utilizes comprehensive strategic marketing programs to create stronger institutional partnerships. Clinical applications include women’s health, encompassing breast cancer and breast reconstruction surgery, gynecology and thyroid surgery. Additional applications include procedures for electrophysiology, spine, orthopedic, cardiothoracic, and general surgery. Invuity is headquartered in San Francisco, CA. For more information, visit www.invuity.com.
CONTACT:
Company Contact:
Jim Mackaness
Chief Financial Officer
Invuity, Inc.
415-655-2129
Investors:
Mark Klausner
Westwicke Partners
443-213-0501
[email protected]
